JP2010539901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010539901A5 JP2010539901A5 JP2010525831A JP2010525831A JP2010539901A5 JP 2010539901 A5 JP2010539901 A5 JP 2010539901A5 JP 2010525831 A JP2010525831 A JP 2010525831A JP 2010525831 A JP2010525831 A JP 2010525831A JP 2010539901 A5 JP2010539901 A5 JP 2010539901A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- line
- composition
- response
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97399307P | 2007-09-20 | 2007-09-20 | |
| PCT/US2008/010883 WO2009038756A2 (en) | 2007-09-20 | 2008-09-19 | Long interspersed nuclear element polypeptide compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010539901A JP2010539901A (ja) | 2010-12-24 |
| JP2010539901A5 true JP2010539901A5 (enExample) | 2011-10-27 |
Family
ID=40468692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525831A Pending JP2010539901A (ja) | 2007-09-20 | 2008-09-19 | 長鎖散在反復配列ポリペプチド組成物およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110046042A1 (enExample) |
| EP (1) | EP2200637A4 (enExample) |
| JP (1) | JP2010539901A (enExample) |
| KR (1) | KR20100075483A (enExample) |
| CN (1) | CN101969987A (enExample) |
| AU (1) | AU2008301888A1 (enExample) |
| BR (1) | BRPI0817209A2 (enExample) |
| CA (1) | CA2700115A1 (enExample) |
| MX (1) | MX2010003110A (enExample) |
| RU (1) | RU2010115088A (enExample) |
| WO (1) | WO2009038756A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| CA2638823A1 (en) | 2006-02-13 | 2007-08-23 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| US8647640B2 (en) | 2009-06-24 | 2014-02-11 | Richard E. COWART | Vaccine compositions and methods of use to protect against infectious disease |
| US20140031250A1 (en) * | 2010-10-07 | 2014-01-30 | David Tsai Ting | Biomarkers of Cancer |
| WO2014004945A1 (en) * | 2012-06-28 | 2014-01-03 | University Of Louisville Research Foundation, Inc. | Use of protein line-1 orf-1 as a biomarker for cancer |
| ES2723885T3 (es) | 2012-07-19 | 2019-09-03 | Daiichi Sankyo Co Ltd | Anticuerpos anti-Siglec-15 |
| EP3760208B1 (en) | 2014-06-25 | 2024-05-29 | The General Hospital Corporation | Targeting human satellite ii (hsatii) |
| WO2016159377A1 (ja) * | 2015-04-03 | 2016-10-06 | 国立大学法人京都大学 | がんの治療薬のスクリーニング方法 |
| GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| CA3154827A1 (en) * | 2019-10-16 | 2021-04-22 | Valerio Orlando | Methods for modulating human l1 retrotransposons rna and compositions for use therein |
| EP4081309A4 (en) * | 2019-12-26 | 2024-01-17 | The Johns Hopkins University | ENHANCED LINE-1 ENCODED ORF2P EXPRESSION FOR CANCER THERAPEUTIC AGENTS |
| JP7569054B2 (ja) | 2020-06-02 | 2024-10-17 | 学校法人東京女子医科大学 | Ｓ１００ａ８阻害ペプチドとこれを含む疾患治療薬 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280108A (en) * | 1991-09-27 | 1994-01-18 | United States Of America | Antibodies to p40 |
| ES2309992T3 (es) * | 1995-10-20 | 2008-12-16 | University Of Nebraska Board Of Regents | Composiciones y procedimientos para incrementar las respuestas inmunes mediadas por celulas presentadoras de antigeno. |
| CN1315379A (zh) * | 2000-03-27 | 2001-10-03 | 上海博德基因开发有限公司 | 一种新的多肽——人L1因子p40蛋白12和编码这种多肽的多核苷酸 |
| CN1315332A (zh) * | 2000-03-27 | 2001-10-03 | 上海博德基因开发有限公司 | 一种新的多肽——l1－12和编码这种多肽的多核苷酸 |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US7700359B2 (en) * | 2000-06-02 | 2010-04-20 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells |
| CN1339478A (zh) * | 2000-08-21 | 2002-03-13 | 上海博德基因开发有限公司 | 一种新的多肽——人l1因子orf2相关蛋白10.78和编码这种多肽的多核苷酸 |
| CN1339450A (zh) * | 2000-08-21 | 2002-03-13 | 上海博德基因开发有限公司 | 一种新的多肽——转座元蛋白14.41和编码这种多肽的多核苷酸 |
| CN1343776A (zh) * | 2000-09-19 | 2002-04-10 | 上海博德基因开发有限公司 | 一种新的多肽——dna聚合酶9.02和编码这种多肽的多核苷酸 |
| CN1352094A (zh) * | 2000-11-06 | 2002-06-05 | 上海博德基因开发有限公司 | 一种新的多肽——人l1元件类蛋白19.80和编码这种多肽的多核苷酸 |
| CN1425684A (zh) * | 2001-12-19 | 2003-06-25 | 复旦大学 | 一种多肽——人反转录转座40蛋白－12.76和编码这种多肽的多核苷酸 |
| WO2004039952A2 (en) * | 2002-10-25 | 2004-05-13 | Five Prime Therapeutics, Inc. | Methods of use for novel human polypeptides encoded by polynucleotides |
| EP1609107A4 (en) * | 2003-03-28 | 2006-08-30 | Idm Pharma Inc | METHOD FOR IDENTIFYING OPTIMAL PEPTIDE PITOPARIANTS |
| WO2005049789A2 (en) * | 2003-05-28 | 2005-06-02 | The Johns Hopkins University | Synthetic mammalian retrotransposon gene |
-
2008
- 2008-09-19 AU AU2008301888A patent/AU2008301888A1/en not_active Abandoned
- 2008-09-19 WO PCT/US2008/010883 patent/WO2009038756A2/en not_active Ceased
- 2008-09-19 KR KR1020107007557A patent/KR20100075483A/ko not_active Withdrawn
- 2008-09-19 JP JP2010525831A patent/JP2010539901A/ja active Pending
- 2008-09-19 BR BRPI0817209-9A2A patent/BRPI0817209A2/pt not_active Application Discontinuation
- 2008-09-19 US US12/677,278 patent/US20110046042A1/en not_active Abandoned
- 2008-09-19 RU RU2010115088/15A patent/RU2010115088A/ru unknown
- 2008-09-19 CA CA2700115A patent/CA2700115A1/en not_active Abandoned
- 2008-09-19 EP EP08832080A patent/EP2200637A4/en not_active Withdrawn
- 2008-09-19 MX MX2010003110A patent/MX2010003110A/es not_active Application Discontinuation
- 2008-09-19 CN CN2008801164478A patent/CN101969987A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010539901A5 (enExample) | ||
| JP7551157B2 (ja) | Ｈｉｖワクチン接種および免疫療法 | |
| RU2010115088A (ru) | Композиции на основе line-полипептида и способы их применения | |
| JP2012509340A5 (enExample) | ||
| JP2024099855A (ja) | Ｈｉｖ予備免疫化および免疫療法 | |
| JP7260170B2 (ja) | 事前の免疫化ステップのないｈｉｖ免疫療法 | |
| JP2014534202A5 (enExample) | ||
| CN106999571B (zh) | 诱导针对人免疫缺陷病毒感染的保护性免疫性的方法和组合物 | |
| JP2019526580A5 (enExample) | ||
| JP2015529678A5 (enExample) | ||
| JP2019527055A5 (enExample) | ||
| JP2016534034A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| JP2006020648A5 (enExample) | ||
| RU2009106089A (ru) | Композиции, содержащие полипептид эндогенного ретровируса человека, и способы их применения | |
| Alfano et al. | New players in cytokine control of HIV infection | |
| EA201591213A1 (ru) | Вакцины против вируса гепатита b | |
| JP2017501986A5 (ja) | 二重特異性ｈｉｖ−１中和抗体 | |
| JP2008526764A5 (enExample) | ||
| JP2015514132A (ja) | ヒト呼吸器合胞体ウイルスコンセンサス抗原、核酸構築物、およびそれらから作製されるワクチン、ならびにその使用方法 | |
| JP2014509838A5 (enExample) | ||
| JP2014527526A5 (enExample) | ||
| JP2014139185A5 (enExample) | ||
| JP2008539164A5 (enExample) | ||
| RU2020125098A (ru) | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита |